Decreased exposure to sunitinib due to concomitant administration of ifosfamide: results of a phase I and pharmacokinetic study on the combination of sunitinib and ifosfamide in patients with advanced solid malignancies

被引:0
|
作者
P Hamberg
N Steeghs
W J Loos
D van de Biessen
M den Hollander
M Tascilar
J Verweij
H Gelderblom
S Sleijfer
机构
[1] Erasmus University Medical Center Daniel Den Hoed Cancer Center,Department of Medical Oncology
[2] Leiden University Medical Center,Department of Medical Oncology
来源
British Journal of Cancer | 2010年 / 102卷
关键词
sunitinib; ifosfamide; pharmacokinetic; VEGF; drug-interaction; phase I;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1699 / 1706
页数:7
相关论文
共 50 条
  • [21] A Phase I and Pharmacokinetic Study of Ixabepilone in Combination with Carboplatin in Patients with Advanced Solid Malignancies
    Plummer, Ruth
    Woll, Penella
    Fyfe, David
    Boddy, Alan V.
    Griffin, Melanie
    Hewitt, Paula
    Carmichael, James
    Namouni, Fouad
    Cohen, Marvin
    Verrill, Mark
    CLINICAL CANCER RESEARCH, 2008, 14 (24) : 8288 - 8294
  • [22] Phase I and pharmacokinetic study of lapatinib in combination with capecitabine in patients with advanced solid malignancies
    Chu, Quincy S. C.
    Schwartz, Garry
    de Bono, Johann
    Smith, Deborah A.
    Koch, Kevin M.
    Versola, Melissa J.
    Pandite, Lini
    Arya, Nikita
    Curtright, Jan
    Fleming, Ronald A.
    Ho, Peter T. C.
    Rowinsky, Eric K.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (24) : 3753 - 3758
  • [23] A phase I, dose-finding study of sunitinib in combination with irinotecan in patients with advanced solid tumours
    Boven, E.
    Massard, C.
    Armand, J. P.
    Tillier, C.
    Hartog, V.
    Brega, N. M.
    Countouriotis, A. M.
    Ruiz-Garcia, A.
    Soria, J. C.
    BRITISH JOURNAL OF CANCER, 2010, 103 (07) : 993 - 1000
  • [24] Sunitinib in combination with docetaxel in patients with advanced solid tumors: a phase I dose-escalation study
    Robert, Francisco
    Sandler, Alan
    Schiller, Joan H.
    Liu, Glenn
    Harper, Karen
    Verkh, Lev
    Huang, Xin
    Ilagan, Jennifer
    Tye, Lesley
    Chao, Richard
    Traynor, Anne M.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 66 (04) : 669 - 680
  • [25] Sunitinib in combination with docetaxel in patients with advanced solid tumors: a phase I dose-escalation study
    Francisco Robert
    Alan Sandler
    Joan H. Schiller
    Glenn Liu
    Karen Harper
    Lev Verkh
    Xin Huang
    Jennifer Ilagan
    Lesley Tye
    Richard Chao
    Anne M. Traynor
    Cancer Chemotherapy and Pharmacology, 2010, 66 : 669 - 680
  • [26] Sunitinib in combination with mFOLFOX6 chemotherapy in patients with advanced solid tumors: A phase I study
    Leong, S.
    Eckhardt, S.
    Chan, E.
    Chow, L.
    VerMeulen, W.
    Camidge, D.
    Rothenberg, M.
    Chow Maneval, E.
    Chao, R.
    Lockhart, A.
    ANNALS OF ONCOLOGY, 2007, 18 : VII123 - VII123
  • [27] A phase I, dose-finding study of sunitinib in combination with irinotecan in patients with advanced solid tumours
    E Boven
    C Massard
    J P Armand
    C Tillier
    V Hartog
    N M Brega
    A M Countouriotis
    A Ruiz-Garcia
    J C Soria
    British Journal of Cancer, 2010, 103 : 993 - 1000
  • [28] A Phase I Study of Sunitinib Plus Capecitabine in Patients With Advanced Solid Tumors
    Sweeney, Christopher J.
    Chiorean, E. Gabriela
    Verschraegen, Claire F.
    Lee, Fa Chyi
    Jones, Suzanne
    Royce, Melanie
    Tye, Lesley
    Liau, Katherine F.
    Bello, Akintunde
    Chao, Richard
    Burris, Howard A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (29) : 4513 - 4520
  • [29] Phase I clinical and pharmacokinetic study of combination chemotherapy with topotecan and ifosfamide in patients with progressive or relapsed solid tumors.
    C.-P. Schneider
    U. Merkel
    U. Grübner
    R. Kath
    K. Höffken
    A. Hoffmann
    Journal of Cancer Research and Clinical Oncology, 2002, 128 : 313 - 318
  • [30] Phase I study with paclitaxel in combination with ifosfamide in pretreated patients with advanced ovarian carcinoma
    Klaassen, U
    Harstrick, A
    Stahl, M
    Eberhardt, W
    Korn, M
    Strumberg, D
    Becher, R
    Wilke, H
    Seeber, S
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 504 - 504